Atara Biotherapeutics Inc.

(ATRA) Trade

By |

Profile

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing therapeutics for patients with serious life-threatening such as cancer, autoimmune and other viral diseases. The company achieves this through two groups of product candidates, such as allogenic or third-party derived antigen-specific T-cells and molecularly targeted biologics.

Contact Information

Website: www.atarabio.com
Main Phone: +1 650 278-8930
Address: 611 Gateway Boulevard
Address 2: Suite 900
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Isaac E. Ciechanover
Employees: 311
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing therapeutics for patients with serious life-threatening such as cancer, autoimmune and other viral diseases. The company achieves this through two groups of product candidates, such as allogenic or third-party derived antigen-specific T-cells and molecularly targeted biologics.

Contact Information

Website: www.atarabio.com
Main Phone: +1 650 278-8930
Address: 611 Gateway Boulevard
Address 2: Suite 900
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Isaac E. Ciechanover
Employees: 311
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 37.44 $ -2.54 (-6.35%)
Last Price 37.44 Change $ -2.54 Change % -6.35 Tick N/A
Bid 37.00 Bid Size 500.00 Ask 39.68 Ask Size 1,400.00
Open 39.57 High 40.05 Low 37.34 Prev Close 39.98
Last Trade Volume 365,693 52 Wk Hi 54.45 52 Wk Low 27.85
Market Cap 1.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 46,161,657.00 EPS (TTM) -5.27 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 60 208
Number of Buys 9 41
Number of Sells 51 167
Net Activity -129598 -266127
Last 10 Buys Shares
Eric L. Dobmeier 1,000
Eric L. Dobmeier 1,000
Joel S. Marcus 1,000
Joel S. Marcus 1,000
Carol G. Gallagher 1,000
Joel S. Marcus 1,000
Carol G. Gallagher 1,000
Last 10 Sell Shares
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Isaac E. Ciechanover 1,000
Mitchall G. Clark 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 54 54 54 54
Low Target Price Estimate 46 46 46 46
Mean Target Price Estimate 50 50 50 50
Standard Deviation 5.66 5.66 5.66 5.66
Date of Most Recent Estimate 05/09/18 05/09/18 05/09/18 05/09/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 3
Moderate Buy 0 0 0 0
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.14 2.14 2.14 2.2